Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

MRC initiates trial to improve survival of patients with resectable NSCLC

July 8, 1997

Troponin I inhibits breast cancer growth in preclinical trial

July 8, 1997

Navelbine introduced in the U.K.

July 8, 1997

Update on DepoTech's DepoCyt

July 8, 1997

Sanwa Kagaku characterizes analogues of dynemicin A

July 8, 1997

Double identity of Bcl-2 protein described

July 7, 1997

Inhibitors of tyrosine kinase disclosed by Pharmacia & Upjohn

July 7, 1997

Sugen files IND for angiogenesis inhibitor

July 3, 1997

ACT licenses rights to patents related to dendritic cell therapy

July 3, 1997

Kyowa Hakko discovers antitumor compounds in Streptomyces culture

July 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...